CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Director sold 25,000 shares at $10.91 ($272,750)
- 4 Open-market sale Director sold 14,287 shares at $11.97 ($171,015)
- 4 Shares withheld for taxes SVP, Bioservices gave up 632 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 3 Insider Initial Statement of Ownership
- S-1 Offering Registration Statement
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Grant or award EVP, Chief Financial Officer acquired 15,000 shares (grant or award)
- 8-K Event Executive or director change
- 8-K Event Material agreement · Results of operations · New debt or obligation · Regulation FD disclosure
- 8-K Event Unregistered share sale
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
Page 10 of 87 · 1,733 filings